Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 500mg in Comparison to Each Component Administered Alone

This study has been completed.
Information provided by (Responsible Party):
LG Life Sciences Identifier:
First received: May 8, 2012
Last updated: February 2, 2015
Last verified: February 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2015
  Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)